Company registration number 08962048 (England and Wales)
IPURE NUTRITION LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 27 JANUARY 2025
PAGES FOR FILING WITH REGISTRAR
IPURE NUTRITION LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 4
IPURE NUTRITION LIMITED
BALANCE SHEET
AS AT
27 JANUARY 2025
27 January 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
116,459
118,669
Cash at bank and in hand
550
-
0
117,009
118,669
Creditors: amounts falling due within one year
4
(84,290)
(84,339)
Net current assets
32,719
34,330
Capital and reserves
Called up share capital
5
2
2
Profit and loss reserves
32,717
34,328
Total equity
32,719
34,330

For the financial year ended 27 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 28 May 2025 and are signed on its behalf by:
V Chopra
Director
Company registration number 08962048 (England and Wales)
IPURE NUTRITION LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 27 JANUARY 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 28 January 2023
1
44,173
44,174
Year ended 27 January 2024:
Loss and total comprehensive income
-
(9,845)
(9,845)
Issue of share capital
5
1
-
1
Balance at 27 January 2024
2
34,328
34,330
Year ended 27 January 2025:
Loss and total comprehensive income
-
(1,611)
(1,611)
Balance at 27 January 2025
2
32,717
32,719
IPURE NUTRITION LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 27 JANUARY 2025
- 3 -
1
Accounting policies
Company information

Ipure Nutrition Limited is a private company limited by shares incorporated in England and Wales. The registered office is C/o M J Goldman, Hollinwood Business Centre, Albert Street, Oldham, OL8 3QL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

Revenue is earned when, and to the extent that, the company has provided consultancy services.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Basic financial assets, which include debtors and cash, together with basic financial liabilities, including creditors, are initially recognised at transaction cost and not amortised as they are either receivable or payable within one year.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
116,459
118,669
IPURE NUTRITION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 27 JANUARY 2025
- 4 -
4
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,330
960
Taxation and social security
65,633
66,335
Other creditors
17,327
17,044
84,290
84,339
5
Called up share capital
2025
2024
Ordinary share capital
£
£
Issued and fully paid
Ordinary share of £1 each
2
2
2025-01-272024-01-28falsefalsefalse28 May 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityR ChopraV Chopra089620482024-01-282025-01-27089620482025-01-27089620482024-01-2708962048core:ShareCapital2025-01-2708962048core:ShareCapital2024-01-2708962048core:RetainedEarningsAccumulatedLosses2025-01-2708962048core:RetainedEarningsAccumulatedLosses2024-01-2708962048core:ShareCapital2023-01-2708962048core:RetainedEarningsAccumulatedLosses2023-01-2708962048core:ShareCapitalOrdinaryShareClass12025-01-2708962048core:ShareCapitalOrdinaryShareClass12024-01-2708962048bus:Director22024-01-282025-01-2708962048core:RetainedEarningsAccumulatedLosses2023-01-282024-01-27089620482023-01-282024-01-2708962048core:RetainedEarningsAccumulatedLosses2024-01-282025-01-2708962048core:ShareCapital2023-01-282024-01-2708962048core:WithinOneYear2025-01-2708962048core:WithinOneYear2024-01-2708962048core:CurrentFinancialInstruments2025-01-2708962048core:CurrentFinancialInstruments2024-01-2708962048bus:OrdinaryShareClass12024-01-282025-01-2708962048bus:PrivateLimitedCompanyLtd2024-01-282025-01-2708962048bus:SmallCompaniesRegimeForAccounts2024-01-282025-01-2708962048bus:FRS1022024-01-282025-01-2708962048bus:AuditExemptWithAccountantsReport2024-01-282025-01-2708962048bus:Director12024-01-282025-01-2708962048bus:FullAccounts2024-01-282025-01-27xbrli:purexbrli:sharesiso4217:GBP